Davis Gregory D has filed 17 insider transactions across 1 company since November 2024.
Most recent transaction: a grant/award of 225000 shares of SANGAMO THERAPEUTICS, INC ($SGMO) on April 01, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | SANGAMO THERAPEUTICS, INC | $SGMO | Davis Gregory D | Head of Research & Technology | A | Stock Option (Right to Buy) | 225000 | $0.00 | 225,000.0000 | 336,494,489 | 9999.99% | 0.07% |
| Feb. 25, 2026 | SANGAMO THERAPEUTICS, INC | $SGMO | Davis Gregory D | Head of Research & Technology | F | Common Stock | 5119 | $0.47 | 185,111.0000 | 336,494,489 | 2.69% | 0.00% |
| Feb. 24, 2026 | SANGAMO THERAPEUTICS, INC | $SGMO | Davis Gregory D | Head of Research & Technology | F | Common Stock | 832 | $0.47 | 190,230.0000 | 336,494,489 | 0.44% | 0.00% |
| Jan. 22, 2026 | SANGAMO THERAPEUTICS, INC | $SGMO | Davis Gregory D | Head of Research & Technology | F | Common Stock | 7721 | $0.40 | 191,062.0000 | 336,494,489 | 3.88% | 0.00% |
| Nov. 24, 2025 | SANGAMO THERAPEUTICS, INC | $SGMO | Davis Gregory D | Head of Research & Technology | F | Common Stock | 723 | $0.42 | 193,791.0000 | 336,494,489 | 0.37% | 0.00% |
| Oct. 22, 2025 | SANGAMO THERAPEUTICS, INC | $SGMO | Davis Gregory D | Head of Research & Technology | F | Common Stock | 6708 | $0.66 | 194,514.0000 | 224,710,019 | 3.33% | 0.00% |
| Aug. 24, 2025 | SANGAMO THERAPEUTICS, INC | $SGMO | Davis Gregory D | Head of Research & Technology | F | Common Stock | 723 | $0.59 | 201,222.0000 | 224,710,019 | 0.36% | 0.00% |
| July 22, 2025 | SANGAMO THERAPEUTICS, INC | $SGMO | Davis Gregory D | Head of Research & Technology | F | Common Stock | 6708 | $0.48 | 201,945.0000 | 224,710,019 | 3.21% | 0.00% |
| May 24, 2025 | SANGAMO THERAPEUTICS, INC | $SGMO | Davis Gregory D | Head of Research & Technology | F | Common Stock | 723 | $0.47 | 208,653.0000 | 224,710,019 | 0.35% | 0.00% |
| April 22, 2025 | SANGAMO THERAPEUTICS, INC | $SGMO | Davis Gregory D | Head of Research & Technology | F | Common Stock | 6708 | $0.78 | 209,376.0000 | 224,710,019 | 3.10% | 0.00% |
| Feb. 25, 2025 | SANGAMO THERAPEUTICS, INC | $SGMO | Davis Gregory D | Head of Research & Technology | A | Common Stock | 49726 | $0.00 | 216,084.0000 | 0 | 29.89% | 0.00% |
| Feb. 25, 2025 | SANGAMO THERAPEUTICS, INC | $SGMO | Davis Gregory D | Head of Research & Technology | A | Stock Option (Right to Buy) | 99454 | $0.00 | 99,454.0000 | 0 | 9999.99% | 0.00% |
| Feb. 25, 2025 | SANGAMO THERAPEUTICS, INC | $SGMO | Davis Gregory D | Head of Research & Technology | F | Common Stock | 507 | $0.96 | 166,358.0000 | 0 | 0.30% | 0.00% |
| Feb. 24, 2025 | SANGAMO THERAPEUTICS, INC | $SGMO | Davis Gregory D | Head of Research & Technology | F | Common Stock | 705 | $1.00 | 166,865.0000 | 0 | 0.42% | 0.00% |
| Jan. 22, 2025 | SANGAMO THERAPEUTICS, INC | $SGMO | Davis Gregory D | Head of Research & Technology | F | Common Stock | 30456 | $1.15 | 167,570.0000 | 0 | 15.38% | 0.00% |
| Nov. 25, 2024 | SANGAMO THERAPEUTICS, INC | $SGMO | Davis Gregory D | Head of Research & Technology | F | Common Stock | 505 | $1.94 | 201,863.0000 | 0 | 0.25% | 0.00% |
| Nov. 24, 2024 | SANGAMO THERAPEUTICS, INC | $SGMO | Davis Gregory D | Head of Research & Technology | F | Common Stock | 721 | $1.88 | 202,368.0000 | 0 | 0.36% | 0.00% |